Blank, Christian U; Lucas, Minke W; Scolyer, Richard A; van de Wiel, Bart A; Menzies, Alexander M; Lopez-Yurda, Marta; Hoeijmakers, Lotte L; Saw, Robyn P M; Lijnsvelt, Judith M; Maher, Nigel G; Pulleman, Saskia M; Gonzalez, Maria; Torres Acosta, Alejandro; van Houdt, Winan J; Lo, Serigne N; Kuijpers, Anke M J; Spillane, Andrew; Klop, W Martin C; Pennington, Thomas E; Zuur, Charlotte L; Shannon, Kerwin F; Seinstra, Beatrijs A; Rawson, Robert V; Haanen, John B A G; Ch'ng, Sydney; Naipal, Kishan A T; Stretch, Jonathan; van Thienen, Johannes V; Rtshiladze, Michael A; Wilgenhof, Sofie; Kapoor, Rony; Meerveld-Eggink, Aafke; Grijpink-Ongering, Lindsay G; van Akkooi, Alexander C J; Reijers, Irene L M; Gyorki, David E; Grünhagen, Dirk J; Speetjens, Frank M; Vliek, Sonja B; Placzke, Joanna; Spain, Lavinia; Stassen, Robert C; Amini-Adle, Mona; Lebbé, Céleste; Faries, Mark B; Robert, Caroline; Ascierto, Paolo A; van Rijn, Rozemarijn; van den Berkmortel, Franchette W P J; Piersma, Djura; van der Westhuizen, Andre; Vreugdenhil, Gerard; Aarts, Maureen J B; Stevense-den Boer, Marion A M; Atkinson, Victoria; Khattak, Muhammad; Andrews, Miles C; van den Eertwegh, Alfons J M; Boers-Sonderen, Marye J; Hospers, Geke A P; Carlino, Matteo S; de Groot, Jan-Willem B; Kapiteijn, Ellen; Suijkerbuijk, Karijn P M; Rutkowski, Piotr; Sandhu, Shahneen; van der Veldt, Astrid A M; Long, Georgina V
(Massachussetts Medical Society, 2024-11-07)
Background In phase 1-2 trials in patients with resectable, macroscopic stage III melanoma, neoadjuvant immunotherapy was more efficacious than adjuvant immunotherapy. Methods In this phase 3 trial, we randomly assigned ...